1. In Silico and in Vitro Study of Trace Amines (TA) and Dopamine (DOP) Interaction with Human Alpha 1-Adrenergic Receptor and the Bacterial Adrenergic Receptor QseC
- Author
-
Arif Luqman, Ruben Amian Ruiz, Viol Dhea Kharisma, and Friedrich Götz
- Subjects
0301 basic medicine ,Adrenergic receptor ,Physiology ,Dopamine ,lcsh:Physiology ,lcsh:Biochemistry ,03 medical and health sciences ,0302 clinical medicine ,Receptors, Adrenergic, alpha-1 ,LNCaP ,Animals ,Humans ,lcsh:QD415-436 ,Computer Simulation ,Amines ,Phosphorylation ,Kinase activity ,Receptor ,Trace amine ,Alpha-1 adrenergic receptor ,lcsh:QP1-981 ,Kinase ,Chemistry ,Escherichia coli Proteins ,Histidine kinase ,Molecular biology ,Trace Elements ,Molecular Docking Simulation ,030104 developmental biology ,030220 oncology & carcinogenesis ,Signal Transduction - Abstract
Background/aims Trace amines (TA) are small organic compounds that have neuromodulator activity due to their interaction with some neuron-related receptors, such as trace amine associated receptors (TAARs), α2-adrenergic receptor (α2-AR) and s-adrenergic receptor (s-AR). However, there is little information on whether TA and dopamine (DOP) can interact with other adrenergic receptors (ARs) such as the mammalian α1-AR and the bacterial counterpart QseC, which is involved in quorum sensing of some Gram-negative pathogens. The aim of this study was to investigate the interaction of TA and DOP with α1-AR and QseC. Methods We performed an in silico study using 3D structure from SWISS MODEL and analyzed the protein interaction via molecular docking using PyMol, PoseView and PyRX 8.0. For the in vitro study, we investigated the QseC kinase activity by measuring the remaining ATP in a reaction containing QseC-enriched membrane incubated together with purified QseB and EPI, TA, DOP, or PTL respectively. We also measured the intracellular Ca++ levels, which represents the α1-AR activation, in LNCAP (pancreatic cell line) cells treated with EPI, TA, DOP and PTL respectively using a fluorescence-based assay. The LNCAP cell proliferation was measured using an MTT-based assay. Results Our in silico analysis revealed that TAs and DOP have high binding affinity to the human α1-AR and the bacterial adrenergic receptor (QseC), comparable to epinephrine (EPI). Both are membrane-bound kinases. Experimental studies with pancreatic cell line (LNCAP) showed that the TAs and DOP act as α1-AR antagonist by counteracting the effect of EPI. In the presence of EPI, TA and DOP trigger an increase of the intracellular Ca++ levels in the LNCAP cells leading to an inhibition of cell proliferation. Although in silico data suggest an interaction of TA and DOP with QseC, they do not inhibit the kinase activity of QseC, a histidine kinase receptor involved in quorum sensing which is also sensitive to EPI. Conclusion Our study showed that the TAs and DOP act as α1-AR antagonist but no effect was observed for QseC.
- Published
- 2020
- Full Text
- View/download PDF